1 From the Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago (M.C.G.); and the Department of Oncology, Institute of Pharmacological Research Mario Negri, Istituto di Ricovero e Cura a Carattere Scientifico, Milan (V.T.).